Your browser doesn't support javascript.
loading
Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy.
Brogden, Kim A; Parashar, Deepak; Hallier, Andrea R; Braun, Terry; Qian, Fang; Rizvi, Naiyer A; Bossler, Aaron D; Milhem, Mohammed M; Chan, Timothy A; Abbasi, Taher; Vali, Shireen.
Afiliación
  • Brogden KA; Iowa Institute for Oral Health Research, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA. kim-brogden@uiowa.edu.
  • Parashar D; Cellworks Research India Ltd., Whitefield, Bangalore, 560066, India.
  • Hallier AR; Biomedical Engineering, The University of Iowa, 5318 SC, Iowa City, IA, 52242, USA.
  • Braun T; Biomedical Engineering, The University of Iowa, 5318 SC, Iowa City, IA, 52242, USA.
  • Qian F; Iowa Institute for Oral Health Research, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA.
  • Rizvi NA; Division of Biostatistics and Research Design, College of Dentistry, The University of Iowa, 801 Newton Road, Iowa City, IA, 52242, USA.
  • Bossler AD; Division of Hematology/Oncology, Columbia University Medical Center, 177 Fort Washington Avenue, New York, NY, 10032, USA.
  • Milhem MM; Molecular Pathology Laboratory, Department of Pathology, University of Iowa Hospitals and Clinics, 200 Hawkins Dr., C606GH, Iowa City, IA, 52242, USA.
  • Chan TA; Clinical Services, Experimental Therapeutics, Melanoma and Sarcoma Program, Holden Comprehensive Cancer Center, The University of Iowa, Iowa City, IA, 52242, USA.
  • Abbasi T; Department of Radiation Oncology, Human Oncology and Pathogenesis Program, Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Vali S; Cellworks Group, Inc., 2033 Gateway Place Suite 500, San Jose, CA, 95110, USA.
BMC Cancer ; 18(1): 225, 2018 02 27.
Article en En | MEDLINE | ID: mdl-29486723

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Simulación por Computador / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Simulación por Computador / Carcinoma de Pulmón de Células no Pequeñas / Anticuerpos Monoclonales Humanizados / Antígeno B7-H1 / Receptor de Muerte Celular Programada 1 / Inmunoterapia Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos